Clinical trial
Longitudinal Evaluation of Direct Neurotization Technique in Breast Reconstruction With Fully Autologous Components: An Assessment of BREAST-Q Sensation Module, Cutaneous Pressure Threshold, Neuregulin 1 (NRG1) Expression, Nerve Fiber Cross-sectional Area, Intraepidermal Nerve Fiber Density (IENFD), and Breast Morphometry
NCT07308275 is registered in ClinicalTrials.gov with Fakultas Kedokteran Universitas Indonesia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Longitudinal Evaluation of Direct Neurotization Technique in Breast Reconstruction With Fully Autologous Components: An Assessment of BREAST-Q Sensation Module, Cutaneous Pressure Threshold, Neuregulin 1 (NRG1) Expression, Nerve Fiber Cross-sectional Area, Intraepidermal Nerve Fiber Density (IENFD), and Breast Morphometry
- Lead sponsor
- Fakultas Kedokteran Universitas Indonesia
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- December 15, 2025
- Completion date
- April 15, 2027
- Enrollment
- 28 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast reconstruction after mastectomy, mastectomy and breast reconstruction, neurotization, peripheral nerve regeneration, quality of life (qol), sensory function